Wearable sensor may replace the dreaded glucose drink test for gestational diabetes

NCT ID NCT06357728

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study tests whether a continuous glucose monitor (CGM) worn on the arm can diagnose gestational diabetes as well as the standard oral glucose tolerance test (OGTT). Pregnant women of Chinese or Indian ethnicity will wear the sensor for up to 10 days and also undergo the OGTT. Researchers will compare glucose readings from both methods and see which better predicts pregnancy outcomes. The goal is to find a more comfortable and informative way to diagnose gestational diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Continuous glucose monitoring (CGM) sensor (Dexcom G6)
What this could lead to
If successful, this could lead to a more comfortable and detailed way to diagnose gestational diabetes, potentially replacing the oral glucose tolerance test.
What could go wrong
This is a small pilot study, so results may not apply to all populations. The CGM sensor may cause skin irritation, and its accuracy compared to the standard test is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    RECRUITING

    Singapore, Singapore, 229899, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.